Document is current
Any future updates will be listed below
-
Authors
Drainas, Alexandros P.
McIlwain, David R.
Dallas, Alec
Chu, Theresa
Delgado-González, Antonio https://orcid.org/0000-0002-4760-8174
Baron, Maya
Angulo-Ibáñez, Maria
Trejo, Angelica
Bai, Yunhao
Hickey, John W.
Lu, Guolan
Lu, Scott
Pineda-Ramirez, Jesus
Anglin, Khamal
Richardson, Eugene T. https://orcid.org/0000-0001-8437-0671
Prostko, John C.
Frias, Edwin
Servellita, Venice https://orcid.org/0000-0002-1745-4012
Brazer, Noah
Chiu, Charles Y. https://orcid.org/0000-0003-2915-2094
Peluso, Michael J.
Martin, Jeffrey N.
Wirz, Oliver F. https://orcid.org/0000-0003-0377-6464
Pham, Tho D.
Boyd, Scott D.
Kelly, J. Daniel
Sage, Julien
Nolan, Garry P. https://orcid.org/0000-0002-8862-9043
Rovira-Clavé, Xavier https://orcid.org/0000-0001-9994-7007
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (75D30122C014367, 75D30120C08009)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (3U19AI100627-09S2, 3U19AI100627-09S2)
- License Information
-
More Information
Article History
Received: 16 August 2023
Accepted: 12 January 2025
First Online: 12 February 2025
Competing interests
: A.P.D., J.S., G.P.N. and X.R.-C. have filed patent applications that cover some aspects of the technology described in this article. The patent with application number PCT/US2022/011620 was filed at the United States, Canada and European Patent Office. A.P.D., D.R.M., J.S., G.P.N. and X.R.-C. are cofounders and shareholders of Capture Bioscience, Inc. M.A.-I. is shareholder of Capture Bioscience, Inc. The other authors declare no competing interests.
